Full-Time
Research Associate III/Sr. Research Associate
Confirmed live in the last 24 hours
Develops medicines for genetic diseases
$105k - $115kAnnually
Mid
San Bruno, CA, USA
BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company operates using a decentralized subsidiary model, where each subsidiary concentrates on creating therapies for particular diseases while sharing central resources. This structure enhances efficiency and allows for the simultaneous advancement of multiple drug programs. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Unlike many competitors, BridgeBio emphasizes independent thinking and transparency, enabling rapid, data-driven decision-making. The company's goal is to create significant therapeutic advancements by targeting diseases at their genetic source, ultimately bringing effective treatments to market more quickly.
Company Stage
IPO
Total Funding
$6.8B
Headquarters
Palo Alto, California
Founded
2014